MedTrace Logo

Effect of Diosmin and Hesperidin in Treatment of Patients With Rheumatoid Arthritis

NCT05756179 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2025-04-25

No results posted yet for this study

Summary

Evaluating the effect of the flavonoids combination (diosmin and hesperidin) as adjuvant therapy on patients with rheumatoid arthritis

Conditions

Interventions

DRUG

Diosmin and Hesperidin Combination

Diosmin 450 mg and Hesperidin 50 mg Combination

Sponsors & Collaborators

  • Alexandria University

    lead OTHER

Principal Investigators

  • AHMED ABDELBAR, MSc · College of Pharmacy - Arab Academy for Science and Technology

  • AHMED ELMALLAH, PhD · Faculty of Pharmacy - Alexandria University

  • MANAL TAYEL, MD · Faculty of Medicine - Alexandria Univeristy

  • ABEER IBRAHIM, MD · Faculty of Medicine - Alexandria Univeristy

  • NOHA HAMDI, PhD · Faculty of Pharmacy - Alexandria University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-18
Primary Completion
2025-09-30
Completion
2026-09-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05756179 on ClinicalTrials.gov